Source:http://linkedlifedata.com/resource/pubmed/id/17277133
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2007-2-5
|
pubmed:abstractText |
The role of tumor-produced chemokines in the growth of malignancies remains poorly understood. We retrieved an in vivo growing MCA205 fibrosarcoma and isolated tumor cell clones that produce both CXCL9/monokine induced by IFN-gamma (Mig) and CXCL10/IFN-gamma-inducible protein 10 following stimulation with IFN-gamma and clones that produce IFN-gamma-inducible protein 10 but not Mig. The Mig-deficient variants grew more aggressively as cutaneous tumors in wild-type mice than the Mig-producing tumor cells. The growth of Mig-expressing, but not Mig-deficient, tumor cells was suppressed by NK and T cell activity. Transduction of Mig-negative variants to generate constitutive tumor cell production of Mig resulted in T cell-dependent rejection of the tumors and in induction of protective tumor-specific CD8(+) T cell responses to Mig-deficient tumors. The results indicate a critical role for tumor-derived Mig in T cell-mediated responses to cutaneous fibrosarcomas and suggest the loss of Mig expression as a mechanism used by tumor cells to evade these responses.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CXCL9,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokines, CXC,
http://linkedlifedata.com/resource/pubmed/chemical/Cxcl9 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Monokines,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
178
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2278-86
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:17277133-Animals,
pubmed-meshheading:17277133-CD8-Positive T-Lymphocytes,
pubmed-meshheading:17277133-Cell Line, Tumor,
pubmed-meshheading:17277133-Chemokine CXCL9,
pubmed-meshheading:17277133-Chemokines, CXC,
pubmed-meshheading:17277133-Fibrosarcoma,
pubmed-meshheading:17277133-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:17277133-Interferon-gamma,
pubmed-meshheading:17277133-Killer Cells, Natural,
pubmed-meshheading:17277133-Mice,
pubmed-meshheading:17277133-Mice, Knockout,
pubmed-meshheading:17277133-Monokines,
pubmed-meshheading:17277133-Neoplasm Proteins,
pubmed-meshheading:17277133-Skin Neoplasms,
pubmed-meshheading:17277133-Tumor Escape
|
pubmed:year |
2007
|
pubmed:articleTitle |
CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors.
|
pubmed:affiliation |
Department of Immunology, Cleveland Clinic, Cleveland, OH 44195, USA. gorbaca@ccf.org
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|